TELYRX HOLDINGS INC.

Pharmaceuticals · Toronto, A6

PharmaceuticalsSEC Form D

TELYRX HOLDINGS INC. filed a Form D with the U.S. Securities and Exchange Commission on April 20, 2026, reporting $12,623,935 raised.

Incorporated in Ontario, Canada and based in Toronto, A6, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that TELYRX HOLDINGS INC. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Vanessa SloweyDirector · Executive Officer
  • John Eric CascioExecutive Officer
  • Adam GardnerExecutive Officer
  • Peter LloydExecutive Officer
  • Rafael JoseExecutive Officer
  • John EusticeExecutive Officer
  • Robert Sean FoleyDirector
  • Michael HandlerDirector
  • Kenneth BernardDirector
  • Andrew BrandtDirector
  • Ransom LangfordDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$3.0MRaised

FibroBiologics, Inc.

PharmaceuticalsHOUSTON, TX
Jun 25, 2026View SEC Form D
$200.0KRaised

Balsam Pharmaceuticals Co

PharmaceuticalsMCLEAN, VA
Jun 10, 2026View SEC Form D
$750.0KRaised

Eos SENOLYTIX, Inc.

PharmaceuticalsHOUSTON, TX
Jun 4, 2026View SEC Form D
$1.9MRaised

Liminatus Pharma, Inc.

PharmaceuticalsFULLERTON, CA
Jun 3, 2026View SEC Form D
$384.8KRaised

Spine BioPharma, Inc.

PharmaceuticalsNEW YORK, NY
May 22, 2026View SEC Form D